Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Cell Physiol Biochem ; 29(3-4): 511-22, 2012.
Article in English | MEDLINE | ID: mdl-22508058

ABSTRACT

The beating cilia play a key role in lung mucociliary transport. The ciliary beating frequency (CBF) and ciliary bend amplitude (CBA) of isolated mouse bronchiolar ciliary cells were measured using a light microscope equipped with a high-speed camera (500 Hz). Procaterol (aß(2)-agonist) increased CBA and CBF in a dose dependent manner via cAMP. The time course of CBA increase is distinct from that of CBF increase: procaterol at 10 nM first increased CBA and then CBF. Moreover, 10 pM procaterol increased CBA, not CBF, whereas 10 nM procaterol increased both CBA and CBF. Concentration-response studies of procaterol demonstrated that the CBA curve was shifted to a lower concentration than the CBF curve, which suggests that CBA regulation is different from CBF regulation. Measurements of microbead movements on the bronchiole of lung slices revealed that 10 pM procaterol increased the rate of ciliary transport by 37% and 10 nM procaterol increased it by 70%. In conclusion, we have shown that increased CBA is of particular importance for increasing the bronchiolar ciliary transport rate, although CBF also plays a role in increasing it.


Subject(s)
Bronchioles/drug effects , Cilia/drug effects , Mucociliary Clearance , Procaterol/pharmacology , Adrenergic beta-2 Receptor Agonists/pharmacology , Albuterol/pharmacology , Animals , Axoneme/metabolism , Axoneme/physiology , Bronchioles/metabolism , Bronchioles/physiology , Calcium/pharmacology , Cilia/metabolism , Cilia/physiology , Cyclic AMP/metabolism , Dose-Response Relationship, Drug , Epithelium/drug effects , Epithelium/metabolism , Epithelium/physiology , Female , In Vitro Techniques , Mice , Mice, Inbred C57BL , Microspheres , Time Factors , Video Recording
2.
Biomed Res ; 29(5): 257-66, 2008 Oct.
Article in English | MEDLINE | ID: mdl-18997441

ABSTRACT

Excessive nitric oxide (NO) generated by inducible nitric oxide synthase (iNOS) aggravates acute lung injury (ALI) by producing peroxinitrite. We previously showed that the expression of iNOS and lung injury were suppressed by inhalation of a novel iNOS inhibitor, ONO-1714, in mice with Candida-induced ALI, and that nitric oxide produced by iNOS and apoptosis of epithelial cells were found to have a crucial role in Candida-induced ALI. In the present study, we investigated the effect of NO on the apoptosis of alveolar epithelial cells in Candida-induced ALI. Mice were pretreated by inhalation of ONO-1714 or saline (vehicle control of ONO-1714), and were given an intravenous injection of Candida albicans to induce ALI. After 24 h from injection of Candida albicans, we performed bronchoalveolar lavage and removed lung tissues. We assessed apoptosis on the basis of TUNEL staining and caspase 3 activity. Our results showed that apoptosis was suppressed by inhibition of iNOS-derived NO production by ONO-1714 inhalation. The augmented production of NO increased FasL, TNF-alpha, and mRNA production of Bax of lung that induced apoptosis of alveolar epithelial cells. Inhibition of iNOS-derived NO production by ONO-1714 inhalation ameliorated Candida-induced ALI and improved survival by suppressing apoptosis of alveolar epithelial cells.


Subject(s)
Acute Lung Injury/pathology , Apoptosis/physiology , Candidiasis/physiopathology , Nitric Oxide Synthase Type II/metabolism , Acute Lung Injury/physiopathology , Amidines/administration & dosage , Amidines/metabolism , Animals , Bronchoalveolar Lavage Fluid/chemistry , Bronchoalveolar Lavage Fluid/cytology , Candida/metabolism , Candidiasis/pathology , Caspase 3/metabolism , Fas Ligand Protein/genetics , Fas Ligand Protein/metabolism , Heterocyclic Compounds, 2-Ring/administration & dosage , Heterocyclic Compounds, 2-Ring/metabolism , Humans , In Situ Nick-End Labeling , Lung/enzymology , Mice , Mice, Inbred BALB C , Nitric Oxide/metabolism , Nitric Oxide Synthase Type II/antagonists & inhibitors , Survival Rate , Tumor Necrosis Factor-alpha/genetics , Tumor Necrosis Factor-alpha/metabolism , Tyrosine/analogs & derivatives , Tyrosine/metabolism , bcl-2-Associated X Protein/genetics , bcl-2-Associated X Protein/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...